KKR Reportedly Eyes $1 Billion-Plus Stake in Medicover's India Hospital Business

KKR is reportedly exploring an acquisition of Medicover's India hospital business for at least $1 billion, according to a source familiar with the matter. No deal has been signed.

KKR is reportedly exploring a purchase of the majority stake in Medicover's India hospital operations for at least $1 billion, according to a source familiar with the matter. Medicover, the Swedish healthcare group, holds approximately 66.9% of Medicover Hospitals India and KKR is said to be seeking to acquire that entire holding, with discussions also extending to minority shareholders. Medicover confirmed it is in discussions with KKR regarding a potential transaction, but stressed there is no certainty the talks will result in a deal and that the company is continuing to pursue its previously announced IPO process in parallel. The exploration is at a non-binding stage, and valuations and terms have not been finalized.

The reported interest fits squarely within KKR's deepening commitment to the Indian healthcare sector. The firm acquired a controlling stake in oncology hospital chain Healthcare Global Enterprises (HCG) in early 2025 for roughly $400 million and subsequently expanded its footprint through Baby Memorial Hospital in Kerala. Medicover Hospitals India operates 26 hospitals with around 6,000 beds, positioning it as one of the larger independent hospital networks in the country. India's private hospital sector has attracted sustained global private equity interest as rising incomes, growing insurance penetration, and chronic under-supply of quality beds create a long-runway growth narrative.

For KKR, a deal at or above the $1 billion mark would represent one of its largest single healthcare commitments in India and could reshape the competitive landscape in the country's fragmented hospital industry. Investors watching KKR should note several open questions: whether Medicover's board ultimately approves a sale versus proceeding with the IPO, what stake size KKR secures, and how quickly regulatory approvals could be obtained. Until a binding agreement is signed and announced, the transaction remains exploratory and the outcome uncertain.

Powered by SentiSense - Intelligent Market Analysis